Literature DB >> 22521182

Screening for posttraumatic stress disorder in civilian substance use disorder patients: cross-validation of the Jellinek-PTSD screening questionnaire.

Debora van Dam1, Thomas Ehring, Ellen Vedel, Paul M G Emmelkamp.   

Abstract

This study aimed to cross-validate earlier findings regarding the diagnostic efficiency of a modified version of the Primary Care Posttraumatic Stress Disorder (PC-PTSD) screening questionnaire (A. Prins, P. Ouimette, R. Kimerling, R. P. Cameron, D. S. Hugelshofer, J. Shaw-Hegwer, et al., 2004). The PC-PTSD is a four-item screening questionnaire for Posttraumatic Stress Disorder (PTSD). Based on former research, we adapted the PC-PTSD for use among civilian substance use disorder (SUD) patients (D. Van Dam, T. Ehring, E. Vedel, & P. M. G. Emmelkamp, 2010). This version will be referred to as the Jellinek-PTSD (J-PTSD) screening questionnaire. Results showed a high sensitivity (.87), specificity (.75), and overall efficiency (.77) of the J-PTSD in detecting PTSD when using a cutoff score of 2. This confirms findings in former research, and suggests that the J-PTSD is a useful screening instrument for PTSD within a civilian SUD population. Both PTSD and SUD are severe and disabling disorders causing great psychological distress. An early recognition of PTSD among SUD patients makes it possible to address PTSD symptoms in time, which may ultimately lead to an improvement of symptoms in this complex patient group.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22521182     DOI: 10.1016/j.jsat.2012.03.005

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  8 in total

1.  The Symptoms of Trauma Scale (SOTS): An Initial Psychometric Study.

Authors:  Julian D Ford; Michaela Mendelsohn; Lewis A Opler; Mark G A Opler; Diya Kallivayalil; Jocelyn Levitan; Michael Pratts; Kristina Muenzenmaier; Anne-Marie Shelley; Michelle S Grennan; Judith Lewis Herman
Journal:  J Psychiatr Pract       Date:  2015-11       Impact factor: 1.325

2.  The relationship between craving and insular morphometry in regular cocaine users: Does sex matter?

Authors:  George S Abdel Malek; Anna E Goudriaan; Anne Marije Kaag
Journal:  Addict Biol       Date:  2022-03       Impact factor: 4.093

3.  Virtual reality, real emotions: a novel analogue for the assessment of risk factors of post-traumatic stress disorder.

Authors:  Pauline Dibbets; Michel A Schulte-Ostermann
Journal:  Front Psychol       Date:  2015-05-22

4.  Self-wise, Other-wise, Streetwise (SOS) training: a novel intervention to reduce victimization in dual diagnosis psychiatric patients with substance use disorders: protocol for a randomized controlled trial.

Authors:  Marleen M de Waal; Martijn J Kikkert; Matthijs Blankers; Jack J M Dekker; Anna E Goudriaan
Journal:  BMC Psychiatry       Date:  2015-10-29       Impact factor: 3.630

5.  Psychometric Properties of the Chinese Version of the Primary Care Post-Traumatic Stress Disorder Screen-5 for Medical Staff Exposed to the COVID-19 Pandemic.

Authors:  Rui-Wen Huang; Tao Shen; Lei-Ming Ge; Lu Cao; Jian-Feng Luo; Shi-Yu Wu
Journal:  Psychol Res Behav Manag       Date:  2021-09-02

6.  Commentary on Nower et al: Patterns in pathways: underlying comorbidities and the importance of assessment.

Authors:  Anna E Goudriaan; Marleen M de Waal
Journal:  Addiction       Date:  2022-03-21       Impact factor: 7.256

7.  Pain Appraisals in Patients with Physical Injury: Assessing the Role of Distress Tolerance in the Relationship between Depression and Pain Catastrophizing.

Authors:  Valerie J Hruschak; Yan Yuan; Whitney Ringwald; Corinne Beaugard; Melissa Repine; Maria Pacella-LaBarbara; Daniel Rosen; Gerald Cochran
Journal:  Health Soc Work       Date:  2021-08-05

8.  Trauma-focused treatment for posttraumatic stress disorder combined with CBT for severe substance use disorder: a randomized controlled trial.

Authors:  Debora van Dam; Thomas Ehring; Ellen Vedel; Paul M G Emmelkamp
Journal:  BMC Psychiatry       Date:  2013-06-19       Impact factor: 3.630

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.